Skip to main content

Find Clinical Trials

Home
Conditions
Stage II Multiple Myeloma

Clinical trial condition

Stage II Multiple Myeloma

Explore clinical trials studying Stage II Multiple Myeloma. Study availability and eligibility vary by location and protocol.

43 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Stage II Multiple Myeloma trial results

Completed

Flavopiridol in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT00047203

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function

NCT00118170

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +83 more
Locations: Cancer and Leukemia Group B (CALGB) Research Base Chicago, Illinois, United States

View Trial Details

Completed

Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications

NCT00799461

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +154 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details